| Literature DB >> 32414004 |
Cecile Borgi1, Mandy Taktouk1, Mona Nasrallah2,3, Hussain Isma'eel3,4, Hani Tamim5,6, Lara Nasreddine1.
Abstract
High dietary glycemic index (GI) and glycemic load (GL) were suggested to increase the risk of metabolic syndrome (MetS). This study aims to estimate dietary GI and GL in a sample of healthy Lebanese adults and examine their association with MetS and its individual abnormalities. The study uses data from a community-based survey of 501 Lebanese urban adults. Dietary intake was assessed using a food frequency questionnaire. Biochemical, anthropometric, and blood pressure measurements were obtained. Subjects with previous diagnosis of chronic disease, metabolic abnormalities, or with incomplete data or implausible energy intakes were excluded, yielding a sample of 283. Participants were grouped into quartiles of GI and GL. Multivariate logistic regression analyses were performed. Average dietary GI and GL were estimated at 59.9 ± 8 and 209.7 ± 100.3. Participants belonging to the highest GI quartile were at increased risk of having MetS (odds ratio (OR) = 2.251, 95% CI:1.120-4.525) but this association lost significance with further adjustments. Those belonging to the second quartile of GI had significantly lower odds of having hyperglycemia (OR: 0.380, 95% CI:0.174-0.833). No associations were detected between GL and MetS. The study contributes to the body of evidence discussing the relationship between GI, GL, and MetS, in a nutrition transition context.Entities:
Keywords: Lebanon; glycemic index; glycemic load; metabolic syndrome; urban adults
Mesh:
Year: 2020 PMID: 32414004 PMCID: PMC7284586 DOI: 10.3390/nu12051394
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Sociodemographic, lifestyle, and anthropometric characteristics and cardiometabolic risk factors in the study population (n = 283) of Lebanese adults and by MetS status.
| All Participants | Participants without MetS | Participants with MetS | |||||
|---|---|---|---|---|---|---|---|
| Variables | Mean or | SD or % | Mean or | SD or % | Mean or | SD or % | |
|
| 40.9 | 13.7 | 38.8 | 12.7 | 44.8 | 14.6 | |
|
| |||||||
| Male | 92 | 32.5 | 46 | 25.4 | 46 | 45.1 | |
| Female | 191 | 67.5 | 135 | 74.6 | 56 | 54.9 | |
|
| |||||||
| Single | 91 | 31.8 | 54 | 29.8 | 36 | 35.3 | |
| Married | 195 | 68.2 | 127 | 70.2 | 66 | 64.7 | |
|
| |||||||
| <600$ | 75 | 28.1 | 42 | 25.6 | 33 | 33 | |
| 600$–2000$ | 167 | 62.5 | 105 | 64 | 60 | 60 | |
| >2000$ | 25 | 9.4 | 17 | 10.4 | 7 | 7 | |
|
| |||||||
| Elementary to intermediate | 147 | 55.5 | 87 | 51.2 | 59 | 64.1 | |
| Secondary or technical | 79 | 29.8 | 49 | 28.8 | 28 | 30.4 | |
| University | 39 | 14.7 | 34 | 20 | 5 | 5.4 | |
|
| |||||||
| Total minutes per day | 110.3 | 81.5 | 113.9 | 85.8 | 103 | 73.3 | |
| Sedentary (minutes/day) | 279.3 | 174.8 | 263.6 | 176.6 | 307.4 | 166.8 | |
|
| |||||||
| No | 63 | 22.3 | 42 | 23.2 | 21 | 20.6 | |
| Yes | 220 | 77.7 | 139 | 76.8 | 81 | 79.4 | |
|
| |||||||
| No | 196 | 69.3 | 115 | 85.6 | 81 | 79.4 | |
| Yes | 47 | 16.6 | 26 | 14.4 | 21 | 20.6 | |
|
| |||||||
| No | 168 | 59.4 | 112 | 61.9 | 56 | 54.9 | |
| Yes | 115 | 40.6 | 69 | 38.1 | 46 | 45.1 | |
|
| |||||||
| BMI (Kg/m2) | 28 | 5.61 | 26.4 | 5 | 31 | 5.4 | |
| Percent Body Fat (%) | 36 | 10.3 | 34.5 | 10.1 | 38.7 | 10.1 | |
| Waist circumference (cm) | 91.9 | 13.5 | 87.1 | 12 | 100.6 | 11.4 | |
|
| |||||||
| Total Cholesterol (mg/dL) | 172.5 | 13.4 | 178.1 | 36.5 | 192.7 | 43.2 | |
| LDL-C (mg/dL) | 99.5 | 14.8 | 101.8 | 31.4 | 116.2 | 38.3 | |
| Triglycerides (mg/dL) | 115 | 60.8 | 96.1 | 50.9 | 164.4 | 80 | |
| HDL-C (MG/DL) | 50.5 | 10.6 | 57 | 16 | 42.9 | 10.9 | |
|
| |||||||
| SBP (mmHg) | 101.2 | 12.4 | 111.7 | 13.2 | 125.5 | 18.4 | |
| DBP (mmHg) | 65 | 7 | 70.3 | 8.2 | 77.4 | 10.3 | |
|
| |||||||
| Fasting blood glucose (mg/dL) | 98.2 | 13.3 | 94 | 7.2 | 105.7 | 17.7 | |
| HbA1c (%) | 5.5 | 0.5 | 5.3 | 0.4 | 5.7 | 0.6 | |
| Insulin (μU/mL) | 26.3 | 15.5 | 23.4 | 8.8 | 31.4 | 22.1 | |
MetS: Metabolic syndrome; BMI: Body Mass Index; LDL-C: Low-Density Lipoprotein-Cholesterol; HDL-C: High-Density Lipoprotein-Cholesterol; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; HbA1c: glycated hemoglobin.
Dietary energy, macronutrients, GI, and GL of participants with and without MetS.
| All Participants | Participants without MetS | Participants with MetS | Significance | |
|---|---|---|---|---|
| Mean ± SD | ||||
|
| 3131.2 ± 1302.6 | 3080.2 ± 1281.6 | 3232.1 ± 1337.9 | 0.347 |
|
| 102.7 ± 3.6 | 103.3 ± 65.8 | 101.9 ± 50.4 | 0.854 |
|
| 13 ± 3.6 | 13.2 ±3.9 | 12.7 ± 3.2 | 0.224 |
|
| 131.8 ± 64.8 | 130.1 ± 63.8 | 134.8± 67.3 | 0.560 |
|
| 39.1 ± 7.9 | 39.4 ± 7.7 | 38.6 ± 8.1 | 0.385 |
|
| 387.55 ± 158.4 | 377.4 ± 150.4 | 407.4 ± 170.2 | 0.126 |
|
| 50.3 ± 8.3 | 50 ± 8.2 | 51 ± 8.4 | 0.360 |
|
| 105 ± 58.5 | 101.5 ± 56.3 | 111.2 ± 61.8 | 0.181 |
|
| 13.8 ± 6 | 13.9 ± 6.4 | 13.6 ± 5.3 | 0.689 |
|
| 28.1 ± 11.8 | 28.7 ± 13.5 | 27.8 ± 10.7 | 0.563 |
|
| 59.9 ± 8 | 59.2 ± 7.8 | 61.2 ± 8.2 | 0.053 |
|
| 61.2 ± 7.8 | 60.6 ± 7.6 | 62.3 ± 7.9 | 0.076 |
|
| 209.7 ± 100.3 | 201.5 ± 95.8 | 225.8 ± 106.2 | 0.050 |
|
| 213.9 ± 101.2 | 205.9 ± 97 | 229.6 ± 106.8 | 0.058 |
GI: Glycemic index; GL: Glycemic load; MetS: Metabolic syndrome. a Values based on Approach 1 (International table): considering only carbohydrate-rich foods [37]. b Values based on Approach 2: same as Approach 1 in addition to GI and GL values proposed by studies (Schulz et al., 2005; van Bakel et al., 2009) [46,48] and USDA CSFII 94-96 food codes [49] with the help of NutritionistPro records at the American University of Beirut (AUB).
Figure 1Box plot showing the distribution of dietary GI and GL among participants with and without MetS. GI: Glycemic index; GL: Glycemic load; MetS: Metabolic syndrome.
Multivariable logistic regression analyses of MetS by dietary GI 1 and GL 1 quartiles.
| Quartile 1 ( | Quartile 2 ( | Quartile 3 ( | Quartile 4 ( | |
|---|---|---|---|---|
| OR (95% CI) | ||||
| Daily Glycemic Index 1 | ||||
| Crude model | 1 | 1.225 (0.600–2.503) | 1.251 (0.612–2.559) | 2.251 (1.120–4.525) |
| Model 1 a | 1 | 1.093 (0.517–2.311) | 1.138 (0.539–2.402) | 1.483 (0.702–3.134) |
| Model 2 b | 1 | 1.258 (0.547–2.891) | 1.090 (0.473–2.512) | 1.269 (0.546–2.945) |
| Model 3 c | 1 | 1.195 (0.518–2.756) | 0.973 (0.414–2.289) | 1.215 (0.518–2.847) |
| Daily Glycemic Load 1 | ||||
| Crude model | 1 | 1.432 (0.711–2.885) | 1.027 (0.502–2.101) | 1.965 (0.981–3.936) |
| Model 1 a | 1 | 1.330 (0.638–2.774) | 0.672 (0.304–1.485) | 1.572 (0.710–3.480) |
| Model 2 b | 1 | 0.941 (0.407–2.173) | 0.579 (0.236–1.421) | 1.595 (0.657–3.875) |
MetS: Metabolic syndrome; GI: Glycemic index; GL: Glycemic load; OR: Odds ratio; CI: Confidence interval. a Model 1: adjusted for age and gender. b Model 2: adjusted for age, gender, BMI, smoking status, alcohol intake, energy intake, total fiber intake, sedentary behavior, and education level. c Model 3: adjusted for age, gender, BMI, smoking status, alcohol intake, energy intake, total fiber intake, sedentary behavior and education level and percentage of energy from protein and fat. Significant results are shown in bold.